What We're Reading: Page 180
Industry reads hand-picked by our editors
Aug 04, 2020
Aug 03, 2020
-
STAT
A tiny Texas company is running most U.S. drive-thru Covid-19 testing
-
Endpoints News
FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative
-
MedTech Dive
Varian sold to Siemens Healthineers in $16.4B all-cash deal
-
Bloomberg
Johnson & Johnson Spravato Spray Approved for Treating Suicidal People
Jul 31, 2020
-
Reuters
China-backed hackers 'targeted COVID-19 vaccine firm Moderna'
-
The Wall Street Journal
Gilead Raises 2020 Profit Outlook on Remdesivir Demand
-
The Boston Globe
Brigham president resigns from Moderna board after conflict of interest questions raised
-
POLITICO
Vaccine distribution will be 'joint venture' between CDC and Pentagon
Jul 30, 2020
-
MIT Technology Review
Some scientists are taking a DIY coronavirus vaccine, and nobody knows if it’s legal or if it works
-
Evaluate Vantage
Roche doubles down on Tau
-
The Wall Street Journal
FDA Nears Decision Authorizing Covid-19 Treatment With Convalescent Plasma
-
San Francisco Business Times
Genentech eliminates nearly 500 jobs
Jul 29, 2020
-
The New York Times
‘Amazing, Isn’t It?’ Long-Sought Blood Test for Alzheimer’s in Reach
-
Associated Press
Trump seeks political shot in the arm in vaccine push
-
Forbes
Moderna's Mysterious Coronavirus Vaccine Delivery System
-
STAT
Celebs tried Soon-Shiong's cancer therapy. Can it work in a clinical trial?
Jul 28, 2020
-
The New York Times
The Doctor Behind the Disputed Covid Data
-
Endpoints News
After down year, 2020 brings new cash into Massachusetts biotech
-
STAT
Facebook's vaccine misinformation problem faces a new test with Covid-19
-
S&P Global
'Conceivable' Moderna COVID-19 vaccine data may come before US elections – Fauci
Jul 27, 2020
-
NPR
Gene Therapy Sees Encouraging Success In Child With Duchenne Muscular Dystrophy
-
The New York Times
Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine
-
Financial Times
Indivior pays $600m in US opioid settlement
-
Reuters
EU eyes COVID-19 vaccines at less than $40, shuns WHO-led alliance - sources
Previous
